Pacific Biosciences of California Inc (NAS:PACB)
$ 1.16 +0.040 (+3.57%) Market Cap: 360.56 Mil Enterprise Value: 829.82 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 58/100

Q2 2026 Pacific Biosciences of California Inc Earnings Call Transcript

Aug 05, 2026 / 08:30PM GMT
Release Date Price: $1.3 (-9.72%)
Operator

Good day. And welcome to PacBio's second-quarter of 2026 earnings call. (Operator Instructions)

Also, please be aware that today's call is being recorded.

I'd now like to turn the call over to Caylene Parrish from Gilmartin Group. Please go ahead.

Caylene Parrish
GIlmartin Group - Investor Relations

Good afternoon, and welcome to PacBio's second-quarter 2026 earnings conference call. With me today are Mark Van Oene, President and Chief Executive Officer; Jim Gibson, Chief Financial Officer; and Christian Henry, PacBio Board Member and Advisor.

Earlier today, we issued a press release outlining the financial results we'll be discussing on today's call, a copy of which is available on the Investors section of our website at www.pacb.com or as furnished on Form 8-K, available on the Securities and Exchange Commission website at www.sec.gov. A copy of our earnings presentation is also available on the Investors

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot